Performance of Predictive Models in Cervical Cancer Recurrence: A Systematic Review and Meta-Analysis of Biomarkers and Prognosis
DOI:
https://doi.org/10.70112/ajcst-2024.13.2.4271Keywords:
Predictive Analytics Frameworks, Cervical Cancer, Biomarkers, Prognosis, Machine LearningAbstract
This study investigates the use of Predictive Analytics Frameworks (PAF) for identifying biomarkers of recurrent cervical cancer and predicting prognosis. It addresses the limited comprehensive evaluations of the effectiveness of predictive models in this area, despite the growing application of machine learning in healthcare. The purpose of this systematic review and meta-analysis is to assess the performance of predictive analytics models in terms of sensitivity, accuracy, specificity, and the area under the curve (AUC-ROC) for identifying cervical cancer biomarkers and predicting prognosis. To address this research problem, a systematic review and meta-analysis was conducted, covering studies published between 2014 and 2024. A total of 1,515 studies were initially identified from the PubMed and Scopus databases, with 50 research studies meeting the inclusion criteria. Repeated measures ANOVA and meta-analysis were applied using data collected over an 8-year period to evaluate recurrence trends and the predictive power of various models. The findings suggest that predictive analytics models show significant potential for improving diagnostic accuracy in identifying cervical cancer biomarkers. However, the review also highlights several limitations, including the small number of included studies, heterogeneity across studies, and potential bias in retrospective analyses. In conclusion, while predictive analytics frameworks demonstrate promise in improving cervical cancer prognosis and biomarker identification, further research is required to validate these findings and assess their broader clinical utility. The study underscores the importance of continued exploration of predictive models to enhance decision-making in oncology.
References
P. A. Cohen, A. Jhingran, A. Oaknin, and L. Denny, “Cervical cancer,” The Lancet, vol. 393, no. 10167, pp. 169-182, Jan. 2019, doi: 10.1016/S0140-6736(18)32470-X.
C. Gao, C. Zhou, J. Zhuang, L. Liu, and C. L., “MicroRNA expression in cervical cancer: novel diagnostic and prognostic biomarkers,” Wiley Online Library, 2018. [Online]. Available: https://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.27029. Accessed: Feb. 22, 2024.
H. Xue, Z. Sun, W. Wu, D. Du, and S. Liao, “Identification of hub genes as potential prognostic biomarkers in cervical cancer using comprehensive bioinformatics analysis and validation studies,” Cancer Manag. Res., vol. 13, pp. 117-131, 2021, doi: 10.2147/CMAR.S282989.
V. Basic, B. Zhang, J. Domert, U. Pellas, and T. Tot, “Integrative meta-analysis of gene expression profiles identifies FEN1 and ENDOU as potential diagnostic biomarkers for cervical squamous cell carcinoma,” Oncol. Lett., vol. 22, no. 6, pp. 1-9, Dec. 2021, doi: 10.3892/OL. 2021.13101.
W. Xu et al., “Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers,” Signal Transduct. Target Ther., vol. 4, no. 1, 2019, doi: 10.1038/s41392-019-0081-6.
K. Wu, Y. Yi, F. Liu, W. Wu, Y. Chen, and W. Zhang, “Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis,” Oncol. Lett., vol. 16, no. 1, pp. 1003-1009, Jul. 2018, doi: 10.3892/OL.2018.8768.
M. Salvatici et al., “Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence,” Gynecol. Oncol., vol. 142, no. 1, pp. 115-119, Jul. 2016, doi: 10.1016/j.ygyno.2016.04.029.
Y. Li et al., “A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma,” J. Transl. Med., vol. 18, no. 1, pp. 1-12, 2020, doi: 10.1186/s12967-020-02387-9.
X. Qu et al., “Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer,” Cancer Med., vol. 10, no. 19, pp. 6881-6896, Oct. 2021, doi: 10.1002/CAM4.4054.
J. Tu et al., “Tumor DNA methylation profiles enable diagnosis, prognosis prediction, and screening for cervical cancer,” Int. J. Gen. Med., vol. 15, pp. 5809-5821, 2022, doi: 10.2147/IJGM.S352373.
S. Wang and X. Chen, “Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis,” Oncol. Lett., vol. 16, no. 4, pp. 5200-5208, Oct. 2018, doi: 10.3892/OL.2018.9323.
G. Niu, D. Wang, Y. Pei, and L. Sun, “Systematic identification of key genes and pathways in the development of invasive cervical cancer,”Gene, vol. 618, pp. 28-41, Jun. 2017, doi: 10.1016/j.gene.2017.03.018.
P. A. Van Dam et al., “Potential new biomarkers for squamouscarcinoma of the uterine cervix,” ESMO Open, vol. 3, no. 4, Jun. 2018, doi: 10.1136/esmoopen-2018-000352.
H. Z. Qiu et al., “Screening and discovery of new potential biomarkers and small molecule drugs for cervical cancer: A bioinformaticsanalysis,” Technol. Cancer Res. Treat., vol. 19, 2020, doi: 10.1177/1533033820980112.
X. Zhang et al., “Promoter methylation analysis of DKK2 may be apotential biomarker for early detection of cervical cancer,” AsianBiomed., vol. 16, no. 4, pp. 181-189, 2022, doi: 10.2478/abm-2022-0022.
N. P. Long et al., “Systematic assessment of cervical cancer initiationand progression uncovers genetic panels for deep learning-based earlydiagnosis and proposes novel diagnostic and prognostic biomarkers,”Oncotarget, vol. 8, no. 65, pp. 109436-109456, 2017, doi: 10.18632/oncotarget.22689.
M. Rajput et al., “Identification of key genes and construction ofregulatory network for the progression of cervical cancer,” Gene Rep., vol. 21, 2020, doi: 10.1016/j.genrep.2020.100965.
S. S. Saha et al., “Expression signatures of HOX cluster genes incervical cancer pathogenesis: Impact of human papillomavirus type 16 oncoprotein E7,” Oncotarget, vol. 8, no. 22, pp. 36591-36602, May2017, doi: 10.18632/ONCOTARGET.16619.
X. Li et al., “Prediction of lymphovascular space invasion using acombination of tenascin-C, cox-2, and PET/CT radiomics in patientswith early-stage cervical squamous cell carcinoma,” BMC Cancer, vol. 21, no. 1, pp. 1-13, 2021, doi: 10.1186/s12885-021-08596-9.
N. C. Garbett et al., “Strategies for screening and early detection ofanal cancers: a narrative and systematic review and meta-analysis ofcytology, HPV testing, and other biomarkers,” Wiley Online Library, vol. 9, no. 1, p. 84710, Jan. 2014, doi: 10.1371/journal.pone.0084710.
T. Shibata, B. J. Lieblong, T. Sasagawa, and M. Nakagawa, “Thepromise of combining cancer vaccine and checkpoint blockade fortreating HPV-related cancer,” Cancer Treat. Rev., vol. 78, pp. 8-16, Aug. 2019, doi: 10.1016/j.ctrv.2019.07.001.
H. Ding et al., “The new biomarker for cervical squamous cellcarcinoma and endocervical adenocarcinoma (CESC) based on publicdatabase mining,” Biomed. Res. Int., vol. 2020, 2020, doi: 10.1155/2020/5478574.
M. Kori, K. Y. A.-Pl, “Potential biomarkers and therapeutic targets incervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective,” PLOS ONE, vol. 13, no. 7,Jul. 2018, doi: 10.1371/journal.pone.0200717.
M. H. Elias, S. Das, and N. Abdul Hamid, “Candidate genes andpathways in cervical cancer: A systematic review and integratedbioinformatic analysis,” Cancers (Basel), vol. 15, no. 3, Feb. 2023,doi: 10.3390/cancers15030853.
B. Sudha et al., “Identification of hub genes and role of CDKN2A as abiomarker in cervical cancer: An in-silico approach,” Human Gene, vol. 33, p. 201048, Sep. 2022, doi: 10.1016/j.humgen.2022.201048.
I. Khan et al., “LC/MS-based polar metabolite profiling identifiedunique biomarker signatures for cervical cancer and cervicalintraepithelial neoplasia using global and targeted,” Cancers (Basel), vol. 11, p. 511, 2019, doi: 10.3390/cancers11040511.
C. Shang et al., “Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer,”Oncol. Rep., vol. 35, no. 6, pp. 3185-3197, 2016, doi: 10.3892/or.2016.4715.
Z. Dong, X. Chang, L. Xie, Y. Wang, and Y. Hou, “Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervicalsquamous cell carcinoma,” Bioengineered, vol. 13, no. 3, pp. 6100-6112, 2022, doi: 10.1080/21655979.2022.2034705.
F. P. de Abreu et al., “Gene expression analysis in cervical cancerprogression: Towards unveiling alterations from normal to tumoraltissue,” Human Gene, vol. 34, Dec. 2022, doi: 10.1016/j.humgen.2022.201131.
M. Abbas, K. Srivastava, M. Imran, and M. Banerjee, “Geneticpolymorphisms in DNA repair genes and their association with
cervical cancer,” Br. J. Biomed. Sci., vol. 76, no. 3, pp. 117-121, Jul. 2019, doi: 10.1080/09674845.2019.1592884.
P. Mandal et al., “Cervical cancer subtypes harbouring integratedand/or episomal HPV16 portray distinct molecular phenotypes basedon transcriptome profiling of mRNAs and miRNAs,” Cell DeathDiscov., vol. 5, no. 1, Dec. 2019, doi: 10.1038/s41420-019-0154-x.
A. Pasha et al., “Inhibition of inducible nitric oxide synthase (iNOS)by andrographolide and in vitro evaluation of its antiproliferative andproapoptotic effects on cervical cancer,” Oxid. Med. Cell. Longev.,vol. 2021, 2021, doi: 10.1155/2021/6692628.
L. Zhao et al., “Exploration of the molecular mechanisms of cervicalcancer based on mRNA expression profiles and predicted microRNAinteractions,” Oncol. Lett., vol. 15, no. 6, pp. 8965-8972, Jun. 2018,doi: 10.3892/ol.2018.8494.
E. Hunter et al., “Development and validation of blood-basedpredictive biomarkers for response to PD-1/PD-L1 checkpointinhibitors: Evidence of a universal systemic core of 3D immunogenetic profiling across multiple oncological indications,” Cancers (Basel),vol. 15, no. 10, 2023, doi: 10.3390/cancers15102696.
G. U. Kang et al., “Dynamics of fecal microbiota with and withoutinvasive cervical cancer and its application in early diagnosis,” Cancers (Basel), vol. 12, no. 12, pp. 1-13, 2020, doi: 10.3390/cancers12123800.
[36] Y. Xue, S. Chen, J. Qin, Y. Liu, B. Huang, and H. Chen,“Application of deep learning in automated analysis of molecularimages in cancer: A survey,” Contrast Media Mol. Imaging, vol. 2017, 2017, doi: 10.1155/2017/9512370.
S. Bumrungthai et al., “Mathematical modelling of cervicalprecancerous lesion grade risk scores: Linear regression analysis ofcellular protein biomarkers and human papillomavirus E6/E7 RNAstaining patterns,” Diagnostics, vol. 13, no. 6, 2023, doi: 10.3390/diagnostics13061084.
G. O. Chong et al., “Predicting tumor budding status in cervical cancer using MRI radiomics: Linking imaging biomarkers to histologiccharacteristics,” Cancers (Basel), vol. 13, no. 20, 2021, doi: 10.3390/cancers13205140.
C. Y. Bae, B. S. Kim, S. H. Jee, J. H. Lee, and N. D. Nguyen, “A study on survival analysis methods using neural network to prevent cancers,”Cancers (Basel), vol. 15, no. 19, 2023, doi: 10.3390/cancers15194757.
S. Purohit et al., “Senescence-associated secretory phenotypedetermines survival and therapeutic response in cervical cancer,”Cancers (Basel), vol. 12, no. 10, pp. 1-19, 2020, doi: 10.3390/cancers12102899.
S. Sun, X. Gong, and F. Zhang, “Spinal epidural metastasis fromcervical cancer: Report of two cases and literature review,” Gynecol.Oncol. Rep., vol. 44, Dec. 2022, doi: 10.1016/j.gore.2022.101096.
S. Dasari, R. N. D. Shouri, W. Rajendra, and L. Valluru, “Effect ofconcurrent radiochemotherapy and chemotherapy on serum proteinsfor prospective predictors of patients with HPV induced cervicalcancer,” Biomed. Pharmacother., vol. 68, no. 3, pp. 315-320, 2014,doi: 10.1016/j.biopha.2013.12.008.
F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A.Jemal, “Global cancer statistics 2018: GLOBOCAN estimates ofincidence and mortality worldwide for 36 cancers in 185 countries,” CA Cancer J. Clin., vol. 68, no. 6, pp. 394-424, Nov. 2018,doi: 10.3322/caac.21492.
M. Stanca and M. E. Cãpîlna, “Prognostic factors associated with 5-year overall survival in cervical cancer patients treated with radicalhysterectomy followed by adjuvant concurrent chemoradiation therapy at a tertiary care center in eastern Europe,” Diagnostics, vol. 11, no. 3, Mar. 2021, doi: 10.3390/diagnostics11030570.
Z. Ou et al., “Prediction of postoperative pathologic risk factors incervical cancer patients treated with radical hysterectomy by machinelearning,” Curr. Oncol., vol. 29, no. 12, pp. 9613-9629, 2022,doi: 10.3390/curroncol29120755.
Y. Luan, W. Zhang, J. Xie, and J. Mao, “CDKN2A inhibits cellproliferation and invasion in cervical cancer through LDHA-mediatedAKT/mTOR pathway,” Clin. Transl. Oncol., vol. 23, no. 2,pp. 222-228, Feb. 2021, doi: 10.1007/s12094-020-02409-4.
A. Jajodia et al., “Combination of radiomics and machine learning with diffusion-weighted MR imaging for clinical outcome prognosticationin cervical cancer,” Tomography, vol. 7, no. 3, pp. 344-357, 2021,doi: 10.3390/tomography7030031.
S. Altmäe et al., “Meta-signature of human endometrial receptivity: A meta-analysis and validation study of transcriptomic biomarkers,” Sci. Rep., vol. 7, no. 1, Dec. 2017, doi: 10.1038/s41598-017-10098-3.
Q. Zhang, L. Qiao, X. Wang, C. Ding, and J. J. Chen, “UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells,” Cell Cycle, vol. 17, no. 3, pp. 300-308, Feb. 2018, doi: 10.1080/15384101.2017.1403686.
H. Sung et al., “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA Cancer J. Clin., vol. 71, no. 3, pp. 209-249, May 2021, doi: 10.3322/caac.21660.
B. Gousbi and A. R. Mohamed Shanavas, “A study: Breast cancer prediction using data mining techniques,” Asian Journal of Computer Science and Technology, vol. 8, no. S2, pp. 52-56, Mar. 2019, doi: 10.51983/ajcst-2019.8.s2.2025.
E. Onuiri, B. G. Akwaronwu, and K. C. Umeaka, “Environmental and genetic interaction models for predicting lung cancer risk using machine learning: A systematic review and meta-analysis,” Asian
Journal of Computer Science and Technology, vol. 13, no. 1, pp. 45-58, Apr. 2024.
S. Shargunam and G. Rajakumar, “Predictive analysis on sensor data using distributed machine learning,” Asian Journal of Computer Science and Technology, vol. 11, no. 1, pp. 1-4, Apr. 2022, doi: 10.51983/ajcst-2022.11.1.3071.
B. Gousbi and A. R. Mohamed Shanavas, “A study: Breast cancer prediction using data mining techniques,” Asian Journal of Computer Science and Technology, vol. 8, no. S2, pp. 52-56, Mar. 2019, doi: 10.51983/ajcst-2019.8.s2.2025.
A. Journal, C. Science, and T. Issn, “Environmental and genetic interaction models for predicting lung cancer risk using machine learning: A systematic review and meta-analysis,” Asian Journal of Computer Science and Technology, vol. 13, no. 1, 2024.
S. Shargunam and G. Rajakumar, “Predictive analysis on sensor data using distributed machine learning,” Asian Journal of Computer Science and Technology, vol. 11, no. 1, pp. 1-4, Apr. 2022, doi: 10.51983/ajcst-2022.11.1.3071.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Centre for Research and Innovation
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
